Crimson Publishers Publish With Us Reprints e-Books Video articles


Modern Approaches in Drug Designing

Nanoparticles Drug Delivery for Cancer Therapy

  • Open or CloseAsmaa Abdelaziz Mohamed*

    College of Pharmacy, Al-Zahraa University for Women, Iraq

    *Corresponding author: Asmaa Abdelaziz Mohamed, College of Pharmacy, Al-Zahraa University for women, Karbala, Iraq

Submission: January 13, 2024; Published: February 08, 2024

ISSN : 2576-9170
Volume 4 Issue 2


Complex etiology makes cancer a primary cause of death and morbidity. Traditional cancer treatments include chemo, radiation, targeted, and immunotherapy. Although non-specificity, cytotoxicity, and multi-drug tolerance limit cancer treatment. Nanotechnology has transformed cancer diagnosis and treatment. Biocompatibility, lowered toxicity, stability, permeability, retention, and targeted precision make nanoparticles (1-100nm) effective cancer treatments. Nanoparticle kinds vary. Patients’ tumor and tumor environment characteristics determine the nanoparticle medicine delivery device. Nanoparticles revolutionize cancer treatment by reducing adverse effects and overcoming multidrug resistance. New multidrug resistance routes have spurred nanoparticle research. Nano formulations have opened new cancer treatment avenues. Fewer nanodrugs have been approved, and most research is in vitro and in vivo. Nanoparticles, targeting methods, and authorized nanotherapeutics are examined for cancer treatment. We conclude with clinical translation’s pros and downsides.

Keywords:Cancer; Nanoparticles; Formulation

Get access to the full text of this article